041960 — Komipharm International Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapHigh Flyer

Market Cap
KR₩430bn
Enterprise Value
KR₩454bn
Revenue
KR₩59bn

Annual balance sheet for Komipharm International Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,106	13,929	10,805	14,820	22,448
Net Total Accounts Receivable
Net Total Receivables	12,998	13,018	14,315	17,980	21,909
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	44,675	41,452	42,629	50,012	59,935
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	72,063	70,141	66,522	64,239	55,784
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	121,913	115,262	111,751	118,598	122,767
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	39,338	25,685	41,047	52,228	46,233
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	45,637	48,801	51,120	62,260	60,486
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	76,275	66,460	60,631	56,338	62,280
Total Liabilities & Shareholders' Equity	121,913	115,262	111,751	118,598	122,767
Total Common Shares Outstanding